AR
Last reporting period 30 Jun, 2024
Updated 19 Sep, 2024
Last price
—
Market cap $B
0.556
Exchange
XNAS - Nasdaq
-186 %
Last period ROIC
What is ROIC ?
The return on invested capital ratio shows how much Net Operating Profit after Tax a company earns per unit of funds involved in its core business. The value of 20% is the benchmark for Eyestock Rating calculation.
See also Arcturus Therapeutics
Company Analysis
ARCT valuation, rating, competitors, insights and company profile
Eyestock Rating
ARCT financial analysis by Eyestock methodology
Valuation
ARCT valuation using historical relative method
Statements
ARCT Income Statements, Balance Sheet and Cash Flow Statements
Dividends
ARCT dividend yield and annual dividend
The return on invested capital ratio shows how much Net Operating Profit after Tax a company earns per unit of funds involved in its core business. The value of 20% is the benchmark for Eyestock Rating calculation.
Arcturus Therapeutics`s ROIC for the last twelve months ended 2024-06-30 is -186 %
